The photobiomodulation therapy together with the use of cord blood platelet gel could be safely suggested as primary treatment for oral lesions in patients with inherited epidermolysis bullosa

Photodermatol Photoimmunol Photomed. 2020 Jul;36(4):318-321. doi: 10.1111/phpp.12548. Epub 2020 Mar 31.

Authors

Ezio Sindici¹, Lucia Basiglio¹, Adriana Cafaro¹, Luigina Fazio², Antonella Dragonetti², Mariateresa Pugliese², Stefano Carossa¹, Roberto Broccoletti¹, Paolo G Arduino¹

Affiliations

¹ Department of Surgical Sciences, CIR-Dental School, University of Turin, Turin, Italy.
² Torino Cord Blood Bank - Immunohematology and Transfusional Medical Service, A.O.U. Città della Salute e della Scienza, Turin, Italy.

PMID: 32176390
DOI: 10.1111/phpp.12548

No abstract available

Publication types

Letter
Randomized Controlled Trial

MeSH terms

Adolescent
Adult
Blood Platelets*
Child
Child, Preschool
Combined Modality Therapy
Epidermolysis Bullosa / complications
Epidermolysis Bullosa / genetics
Epidermolysis Bullosa / therapy*
Female
Fetal Blood
Gels
Humans
Lasers, Semiconductor / therapeutic use
Low-Level Light Therapy*
Male
Middle Aged
Mouth Mucosa
Pain / etiology
Treatment Outcome
Wound Healing*
Young Adult

Substances

Gels